74243-85-9

Basic information

• Product Name: DIETHYL (2R,3R)-(-)-2,3-EPOXYSUCCINATE
• Synonyms: DIETHYL (2R,3R)-(-)-2,3-EPOXYSUCCINATE;DIETHYL-(2R,3R)-2,3-EPOXYSUCCINATE;(2R,3R)-DIETHYL-2,3-EPOXY SUCCINATE;2,3-Oxiranedicarboxylicacid,diethylester,(2R,3R)-(9CI);diethyl (2R,3R)-oxirane-2,3-dicarboxylate;Oxirane-2,3-dicarboxylic acid diethyl ester;Diethyl (2R,3R)-(-)-2,3-epoxysuccinate,98%;trans-2,3-bis(ethoxycarbonyl)oxirane, (-)-(2R,3R)-trans-Oxiran-2,3-dicarbonsaeure-diethylester, diethyl (2R,3R)-(-)-oxirane-2,3-dicarboxylate, diethyl (2R,3R)-(-)-threo-2,3-epoxysuccinate, (2R,3R)-diethyl oxirane-2,3-dicarboxylate, diethyl (2R,3R)-oxirane-2,3-dicarboxylate, Diethyl (2R,3R)-threo-2,3-epoxysuccinate
• CAS NO: 74243-85-9
• Molecular Formula: C₈H₁₂O₅
• Molecular Weight: 188.18
• Product Categories: EPOXYDE;Chiral Building Blocks;Epoxides;Organic Building Blocks
• Mol File: 74243-85-9.mol
• Article Data: 27

Chemical Properties

• Boiling Point: 234-235 °C(lit.)
• Flash Point: >230 °F
• Appearance: /
• Density: 1.144 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.0549mmHg at 25°C
• Refractive Index: n20/D 1.4380(lit.)
• CAS DataBase Reference: DIETHYL (2R,3R)-(-)-2,3-EPOXYSUCCINATE(CAS DataBase Reference)
• NIST Chemistry Reference: DIETHYL (2R,3R)-(-)-2,3-EPOXYSUCCINATE(74243-85-9)
• EPA Substance Registry System: DIETHYL (2R,3R)-(-)-2,3-EPOXYSUCCINATE(74243-85-9)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36
• WGK Germany: 3
• Hazardous Substances Data: 74243-85-9(Hazardous Substances Data)

Usage

Chemical Properties

clear colorless to pink liquid

Uses

(2R,3R)-Diethyl 2,3-epoxysuccinate may be used in the preparation of ethyl (2R,3S)-4-hydroxy-2,3-epoxybutyrate via reduction using sodium borohydride

InChI:InChI=1/C8H12O5/c1-3-11-7(9)5-6(13-5)8(10)12-4-2/h5-6H,3-4H2,1-2H3/t5-,6-/m1/s1

Upstream product

• 64-17-5 ethanol 
• 17087-75-1 (-)-trans-2,3-oxiranedicarboxylic acid 
• 87-91-2 diethyl (2R,3R)-tartrate 
• 80640-14-8 diethyl (2R,3S)-(-)-erythro-2-hydroxy-3-bromosuccinate 
• 111-70-6 n-heptan1ol 
• 3291-46-1 (2SR,3SR)-oxirane-2,3-dicarboxylic acid diethyl ester 
• 111612-33-0 D-trans-epoxysuccinic acid D-arginine 
• 57968-71-5 (+/-)-diethyl tartrate 
• 13811-71-7 diethyl (2S,3S)-tartrate 
• 141-36-6 DL-trans-epoxysuccinic acid 
• 80640-15-9 diethyl (2S,3R)-(+)-erythro-2-hydroxy-3-bromosuccinate 
• 691-84-9 Diethyl (S)-malate 
• 93713-32-7 (+)-(2S,3S)-trans-Oxiran-2,3-dicarbonsaeure-L-Arginin-Salz 
• 1520-50-9 but-2-enedioic acid diethyl ester 

Downstream Products

• 100464-19-5 2-ethyl 3-(4-nitrophenyl) (2S,3S)-oxirane-2,3-dicarboxylate 
• 1448429-23-9 (2S,3S)-ethyl-3-((S)-1-oxo-1-((1-(4-sulfamoylphenyl)-1H-1,2,3-triazol-4-yl)methylamino)-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-24-0 (2S,3S)-ethyl-3-((S)-1-((1-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,3-triazol-4-yl)methylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-25-1 (2S,3S)-ethyl-3-((S)-1-((1-(4-bromophenyl)-1H-1,2,3-triazol-4-yl)methylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-26-2 (2S,3S)-ethyl-3-((S)-1-((1-(4-nitrophenyl)-1H-1,2,3-triazol-4-yl)methylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-27-3 (2S,3S)-ethyl-3-((S)-1-((1-(2,6-difluorophenyl)-1H-1,2,3-triazol-4-yl)methylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-28-4 (2S,3S)-ethyl-3-((S)-1-((1-mesityl-1H-1,2,3-triazol-4-yl)methylamino)-1-oxo-3-(thiazol-4-yl)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-30-8 (2S,3S)-ethyl 3-((S)-4-methyl-1-oxo-1-(phenylamino)pentan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-31-9 (2S,3S)-ethyl 3-((S)-1-(2,6-difluorophenylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-33-1 (2S,3S)-ethyl 3-((S)-1-(4-(4-fluorophenyl)thiazol-2-ylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-35-3 (2S,3S)-ethyl 3-((S)-1-(4-(4-fluorophenylsulfonamido)butylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-38-6 (2S,3S)-ethyl 3-((S)-3-(1H-imidazol-5-yl)-1-oxo-1-(phenylamino)propan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-39-7 (2S,3S)-ethyl 3-((S)-3-(1H-imidazol-5-yl)-1-(mesitylamino)-1-oxopropan-2-ylcarbamoyl)oxirane-2-carboxylate 
• 1448429-40-0 (2S,3S)-ethyl 3-(1-(4-(4-fluorophenyl)thiazol-2-ylamino)-3-(1H-imidazol-4-yl)-1-oxopropan-2-ylcarbamoyl)oxirane-2-carboxylate 

Relevant articles and documents

Benchtop-Stabssle Hypervalent Bromine(III) Compounds: Versatile Strategy and Platform for Air- And Moisture-Stable λ3-Bromanes

We present the first synthesis of air/moisture-stable λ3-bromanes (9and10) by using a cyclic 1,2-benzbromoxol-3-one (BBX) strategy. X-ray crystallography and NMR and IR spectroscopy ofN-triflylimino-λ3-bromane (12) revealed that the bromine(III) center is effectively stabilized by intramolecular R-Br-O hypervalent bonding. This strategy enables the synthesis of a variety of air-, moisture-, and benchtop-stable Br-hydroxy, -acetoxy, -alkynyl, -aryl, and bis[(trifluoromethyl)sulfonyl]methylide λ3-bromane derivatives.

Approaching an experimental electron density model of the biologically active trans-epoxysuccinyl amide group—Substituent effects vs. crystal packing

The trans-epoxysuccinyl amide group as a biologically active moiety in cysteine protease inhibitors such as loxistatin acid E64c has been used as a benchmark system for theoretical studies of environmental effects on the electron density of small active i

Cysteine protease inhibitors and uses thereof

The invention provides for novel cysteine protease inhibitors and compositions comprising novel cysteine protease derivatives. The invention further provides for methods for treatment of neurodegenerative diseases comprising administration novel cysteine